↓ Skip to main content

Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor

Overview of attention for article published in BMC Cancer, May 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
peer_reviews
1 peer review site

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor
Published in
BMC Cancer, May 2019
DOI 10.1186/s12885-019-5700-7
Pubmed ID
Authors

Chia-Chi Liu, Ching-Fang Yu, Shu-Chi Wang, Hsueh-Yin Li, Chiu-Min Lin, Hsia-Han Wang, Carmen Abate, Chi-Shiun Chiang

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 13%
Student > Bachelor 5 13%
Student > Ph. D. Student 4 11%
Student > Doctoral Student 3 8%
Lecturer > Senior Lecturer 2 5%
Other 6 16%
Unknown 13 34%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 6 16%
Medicine and Dentistry 5 13%
Biochemistry, Genetics and Molecular Biology 4 11%
Chemistry 4 11%
Neuroscience 2 5%
Other 3 8%
Unknown 14 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2019.
All research outputs
#15,046,119
of 23,148,322 outputs
Outputs from BMC Cancer
#3,727
of 8,400 outputs
Outputs of similar age
#205,070
of 350,637 outputs
Outputs of similar age from BMC Cancer
#103
of 219 outputs
Altmetric has tracked 23,148,322 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,400 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,637 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 219 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.